Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

At the IAS 2025 conference in Kigali, Rwanda, Banky Olatosi, M.P.H., M.S., Ph.D., of the University of South Carolina, shed ...

Drexel psychology students created a 'happiness map' of Philadelphia, identifying 28 places from Rittenhouse Square to hidden gems that boost well-being and joy.

HIV’s Most Promising Breakthrough Has Taken a Hit Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more research.

Still, most of the researchers I spoke with insisted that they’ll find a solution soon. The mRNA vaccines for HIV “are not at all dead in the water,” Kublin told me. If needed, scientists could tweak ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more research.

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively and a much lower cost than many existing treatments, an initial ...

Modern HIV medicine is based on a common genetic mutation. Now, researchers have traced where and when the mutation arose -- and how it protected our ancestors from ancient diseases.

A year’s supply of the most common HIV drugs costs $64 (£48) per person, compared with $300 for the medicines used after those drugs fail.